In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 68 for your search:
Country:  U.S.A.
Trial Type:  Screening
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Health services research, Screening
Status: Active
Age: 45 to 65
Sponsor: Other
Protocol IDs: CDC-NCCDPHP-2504, NCT00207636

2.

Phase: Phase III
Type: Behavioral study, Health services research, Screening
Status: Active
Age: 50 to 74
Sponsor: NCI
Protocol IDs: TJUH-2006-44, 2006-44, NCT00617071

3.

Phase: Phase III
Type: Screening
Status: Active
Age: 50 to 79
Sponsor: NCI
Protocol IDs: TJUH-RSGT-08-017-01-CPPB, RSGT-08-017-01-CPPB, 08G.89, NCT00893295

4.

Phase: Phase III
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 112024, NCT00937950

5.

Phase: Phase III
Type: Educational/Counseling/Training, Screening
Status: Active
Age: 18 to 64
Sponsor: NCI, Other
Protocol IDs: P01CA109091-01A1, NCT00760721

6.

Phase: Phase III
Type: Screening
Status: Active
Age: 28 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 113617, NCT01190176

7.

Phase: Phase III
Type: Diagnostic, Screening
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: FMSU2011-003A, NCT01542814

8.

Phase: Phase III
Type: Screening
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 5130003, LLUMCGI2013, NCT01782014

9.

Phase: Phase II, Phase I
Type: Screening
Status: Active
Age: 40 to 80
Sponsor: NIDDK
Protocol IDs: 080173, 08-DK-0173, NCT00719641

10.

Phase: Phase II, Phase I
Type: Diagnostic, Screening
Status: Active
Age: 18 to 80
Sponsor: NCI
Protocol IDs: VAMC-WA-33141, 33141, NCT00903136

11.

Phase: Phase II
Type: Screening
Status: Active
Age: 50 to 70
Sponsor: NCI
Protocol IDs: LLNL-05-104, NCT00354497

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 50 to 80
Sponsor: NCI
Protocol IDs: NCCTG-GLNE010, GLNE 010, GLNE010, NCT01511653

13.

Phase: Phase II
Type: Health services research, Screening
Status: Active
Age: 50 to 120
Sponsor: Other
Protocol IDs: Oncimmune-2550, NCT01700257

14.

Phase: Phase I
Type: Screening
Status: Active
Age: 45 to 80
Sponsor: Other
Protocol IDs: 633, NCT00124163

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Screening
Status: Active
Age: 25 to 80
Sponsor: Other
Protocol IDs: P50CA83636-01, 6973, NCT01121640

16.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 99G8, P30CA060553, NCI-G00-1753, NU-99G7, NCT00005095

17.

Phase: No phase specified
Type: Screening
Status: Active
Age: 30 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069397, MGH-000084, NCT00039559

18.

Phase: No phase specified
Type: Screening
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: NCI-01-DC-0099, NCT00045071

19.

Phase: No phase specified
Type: Screening
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: NCI-02-C-0313, NCT00049621

20.

Phase: No phase specified
Type: Screening
Status: Active
Age: 45 to 80
Sponsor: Other
Protocol IDs: DAMD17-03-1-0447, NCT00117663

21.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Screening
Status: Active
Age: Over 50
Sponsor: Other
Protocol IDs: CDR0000456198, NYU-H-8896-06-B, NCT00301119

22.

Phase: No phase specified
Type: Screening
Status: Active
Age: 50 to 75
Sponsor: NCI, Other
Protocol IDs: 5 R01 HS013912-03, NCT00251862

23.

Phase: No phase specified
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: CASE1105, P30CA043703, NCT00445445

24.

Phase: No phase specified
Type: Behavioral study, Health services research, Screening
Status: Active
Age: 50 and over
Sponsor: NCI
Protocol IDs: FCCC-05016, 05-016, FCCC-IRB-05-016, NCT00459030

25.

Phase: No phase specified
Type: Educational/Counseling/Training, Screening
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: 070504, NCT00534053
1    
New Search